Fundraising FoxBVCF — Full Portfolio
7 tracked investments · listed companies and verified rows first
Jaguar Health is a pharmaceutical company developing crofelemer, including a novel powder for oral solution formulation, for gastrointestinal conditions and rare intestinal failure indications such as microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) in adults and children.
BiotechDigital HealthHealthtechSan Francisco, US
Lisa Conte(Executive Officer, Director)Carol Lizak(Executive Officer)Pravin Chaturvedi(Executive Officer)Steven King(Executive Officer)inJonathan Wolin(Executive Officer)inSerge Martinod(Executive Officer)
Co-investorsDigitalDx Ventures
SPS Commerce is a supply chain and retail network software company that enables retailers, suppliers, and logistics partners to manage inventory, orders, and supply chain operations.
AI & Machine LearningE-commerceLogistics & Supply ChainSaaSMinneapolis, US
Chad Collins(Chief Executive Officer)inJim Frome(Executive Officer)inKim Nelson(Executive Officer)inDan Juckniess(Executive Officer)inJamie Thingelstad(Executive Vice President & Chief Technology Officer)inArchie C. Black(Executive Officer, Director)in
Co-investorsPartinc CapitalSeyen CapitalCID CapitalSplit Rock Partners
DiaCarta is a precision diagnostics company developing molecular technologies (XNA and isobDNA) to detect genetic mutations for cancer patient management—covering early detection, diagnosis, therapy selection, and monitoring—as well as infectious disease testing.
BiotechDigital HealthMedical Devices
Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments.
BiotechHealthtechMedical DevicesBoston, CH
Riad Sherif(Chief Executive Officer)in
Co-investorsBay City CapitalBrunnur Ventures GPPivotal Life SciencesVI Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CARsgen TherapeuticsQiselian Biotechnology
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.